BAP1 and uveal melanoma: Germline carriers of BAP1 pathogenic variants demonstrate earlier onset (e.g. median age of onset in uveal melanoma patients with germline BAP1 mutations is 51 years compared to 62 years in the general population47) and more aggressive cancers15.